ATE479097T1 - Verfahren zur diagnose oder prognostizierung der wesentlichen bakteriellen erreger von atemwegserkrankungen in einem patienten - Google Patents

Verfahren zur diagnose oder prognostizierung der wesentlichen bakteriellen erreger von atemwegserkrankungen in einem patienten

Info

Publication number
ATE479097T1
ATE479097T1 AT02745164T AT02745164T ATE479097T1 AT E479097 T1 ATE479097 T1 AT E479097T1 AT 02745164 T AT02745164 T AT 02745164T AT 02745164 T AT02745164 T AT 02745164T AT E479097 T1 ATE479097 T1 AT E479097T1
Authority
AT
Austria
Prior art keywords
diagnosing
predicting
patient
respiratory diseases
iii
Prior art date
Application number
AT02745164T
Other languages
English (en)
Inventor
Jesper Eugen-Olsen
Original Assignee
Virogates Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogates Aps filed Critical Virogates Aps
Application granted granted Critical
Publication of ATE479097T1 publication Critical patent/ATE479097T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02745164T 2001-05-18 2002-05-21 Verfahren zur diagnose oder prognostizierung der wesentlichen bakteriellen erreger von atemwegserkrankungen in einem patienten ATE479097T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100799 2001-05-18
PCT/DK2002/000341 WO2002095411A1 (en) 2001-05-18 2002-05-21 A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject

Publications (1)

Publication Number Publication Date
ATE479097T1 true ATE479097T1 (de) 2010-09-15

Family

ID=8160511

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745164T ATE479097T1 (de) 2001-05-18 2002-05-21 Verfahren zur diagnose oder prognostizierung der wesentlichen bakteriellen erreger von atemwegserkrankungen in einem patienten

Country Status (11)

Country Link
US (1) US7399602B2 (de)
EP (1) EP1405076B1 (de)
CN (1) CN100340858C (de)
AT (1) ATE479097T1 (de)
BR (1) BRPI0210903B8 (de)
DE (1) DE60237448D1 (de)
DK (1) DK1405076T3 (de)
EA (1) EA005776B1 (de)
ES (1) ES2351690T3 (de)
WO (1) WO2002095411A1 (de)
ZA (1) ZA200309770B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2291226T3 (es) 1999-11-25 2008-03-01 Jesper Eugen-Olsen Un metodo de diagnostico o prognosis de infeccion por vih en un sujeto.
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays
EP2226635B1 (de) * 2007-12-28 2013-03-13 BL Co., Ltd Immundetektionstest für mycobacterium-tuberculosis-komplex
EP2711710B1 (de) * 2011-05-19 2017-04-26 Mochida Pharmaceutical Co., Ltd. Diagnose von atemwegesinfektionskrankheiten anhand von urinproben
GB201211982D0 (en) * 2012-07-05 2012-08-22 Isis Innovation Biomarker
CN106461674A (zh) * 2014-04-15 2017-02-22 斯坦陵布什大学 一种用于诊断结核性脑膜炎的方法
US10094833B2 (en) 2014-08-08 2018-10-09 Randox Laboratories Limited Method and kit for detecting bacterial infection
CN106556703A (zh) * 2016-10-18 2017-04-05 上海凯璟生物科技有限公司 一种慢性肾脏病标志物suPAR检测试剂盒和制备方法
RU2659384C1 (ru) * 2017-07-10 2018-06-29 Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" Способ раннего прогнозирования характера течения острой респираторной инфекции у детей
GB201802795D0 (en) * 2018-02-21 2018-04-04 Virogates As Patient assessment method
FR3080185A1 (fr) * 2018-04-16 2019-10-18 Biomerieux Evaluation du risque de complication chez un patient suspecte d'avoir une infection ayant un score sofa inferieur a deux
CN115516314A (zh) * 2020-04-08 2022-12-23 维罗盖茨有限公司 Sars-cov-2感染风险评估方法
AU2021292488A1 (en) * 2020-06-15 2023-02-02 Monopar Therapeutics, Inc. Precision radioimmunotherapeutic targeting of the urokinase plasminogen activator receptor (uPAR) for treatment of severe COVID-19 disease
RU2765744C2 (ru) * 2020-07-20 2022-02-02 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) Способ определения вероятности летального исхода на основании жалоб у больного туберкулезом с ВИЧ-инфекцией при поступлении в стационар Федеральной службы исполнения наказаний РФ
CN113295874B (zh) * 2021-05-25 2022-03-04 广东源心再生医学有限公司 一种用于瓣膜性心脏病辅助诊断的新型标志物、辅助诊断的产品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845026A (en) * 1985-12-03 1989-07-04 T Cell Sciences, Inc. Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
US5459078A (en) * 1988-01-29 1995-10-17 Abbott Laboratories Methods and reagents for performing ion-capture digoxin assays
US6406873B2 (en) 1998-01-26 2002-06-18 Biotech Australia Pty Ltd PAI-2 and T-PA as diagnostic markers of periodontal disease
US6077508A (en) * 1998-03-23 2000-06-20 American Diagnostica Inc. Urokinase plasminogen activator receptor as a target for diagnosis of metastases
DE19840671A1 (de) 1998-08-26 2000-03-02 Stiftung Tumorbank Basel Verfahren zur Diagnose von Rezidiven bei nodal-negativem Brustkrebs
CA2384295A1 (en) 1999-04-28 2000-11-02 Yahia Gawad Method for determining plasminogen activator inhibitor
ES2291226T3 (es) 1999-11-25 2008-03-01 Jesper Eugen-Olsen Un metodo de diagnostico o prognosis de infeccion por vih en un sujeto.

Also Published As

Publication number Publication date
ZA200309770B (en) 2004-09-28
EP1405076A1 (de) 2004-04-07
WO2002095411A1 (en) 2002-11-28
BRPI0210903B8 (pt) 2021-07-27
EA005776B1 (ru) 2005-06-30
CN1723394A (zh) 2006-01-18
BRPI0210903B1 (pt) 2017-01-17
DE60237448D1 (de) 2010-10-07
BR0210903A (pt) 2004-06-08
CN100340858C (zh) 2007-10-03
US20050100961A1 (en) 2005-05-12
ES2351690T3 (es) 2011-02-09
EA200301271A1 (ru) 2004-06-24
DK1405076T3 (da) 2011-01-03
EP1405076B1 (de) 2010-08-25
US7399602B2 (en) 2008-07-15

Similar Documents

Publication Publication Date Title
ATE479097T1 (de) Verfahren zur diagnose oder prognostizierung der wesentlichen bakteriellen erreger von atemwegserkrankungen in einem patienten
DE69920940D1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
EP1221620A3 (de) Verfahren zum Ausführen einer Bestimmung der "activated clotting time" mit geringer Empfindlichkeit gegenüber die Anwesenheit des Aprotinins sowie zur Ermittlung der Aprotinin-Empfindlichkeit
WO2004055519A3 (en) Specific markers for pancreatic cancer
WO2022056313A3 (en) Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment
ATE315789T1 (de) Elisa für vegf
ATE417125T1 (de) Diagnose von einer klinischen infektion einer wunde
CY1107733T1 (el) Μεθοδος για τον χαρακτηρισμο μιας βιολογικης καταστασης χρησιμοποιωντας βαθμοnομημενα προφιλ γονιδιακης εκφρασης
SE0102919D0 (sv) Medical device
WO2000062070A3 (en) Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
AP1623A (en) A method of diagnosing of prognosticating HIV infection in a subject.
WO2003033009A3 (en) Novel drug targets for arthritis
ATE529743T1 (de) Verfahren und kits zur tumorigenizitätsdiagnose
WO2020023789A3 (en) Small rna predictors for alzheimer's disease
Lijnen Synthetic substrates in clinical blood coagulation assays
DE3875826D1 (de) Methode, vorrichtung und testsatz zur messung der aktivitaet eines gewebeplasminogenaktivators.
WO2003023056A3 (en) Specific markers for multiple sclerosis
AU2001283795A1 (en) Simple methods for the drug monitoring of gpiib/iiia-receptor antagonists
DE60232069D1 (de) Formen prostataspezifischer antigene und verfahren zu deren nachweis
DE60221883D1 (de) Screeningverfahren für einen auf die zellwand wirkenden arzneistoff
DE60144027D1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
IL156282A0 (en) Eg-vegf/prokineticin 2-receptor antagonists
AU9397101A (en) Apparatus and method for measurement of biological structures
ATE386269T1 (de) Verwendung eines markierten liganden mit spezifität für das humane cd4-molekül

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1405076

Country of ref document: EP